 |
TheraBionic
Last updated: April 15, 2024
Boris Pasche, Co-Founder and CEO
Country: Germany | Funding: $40K (+)
Website: https://www.therabionic.com/
The TheraBionic P1 medical device is indicated for the systemic treatment of advanced hepatocellular carcinoma with or without metastases. It emits low levels of radiofrequency electromagnetic fields, which block the growth of tumor cells and do not affect the growth of normal cells.
Website: https://www.therabionic.com/
The TheraBionic P1 medical device is indicated for the systemic treatment of advanced hepatocellular carcinoma with or without metastases. It emits low levels of radiofrequency electromagnetic fields, which block the growth of tumor cells and do not affect the growth of normal cells.
